| First Author | Stayner CK | Year | 1998 |
| Journal | J Biol Chem | Volume | 273 |
| Issue | 39 | Pages | 25472-9 |
| PubMed ID | 9738017 | Mgi Jnum | J:50071 |
| Mgi Id | MGI:1289812 | Doi | 10.1074/jbc.273.39.25472 |
| Citation | Stayner CK, et al. (1998) Cloning and characterization of the human PAX2 promoter. J Biol Chem 273(39):25472-9 |
| abstractText | PAX2, a member of the PAX gene family of developmental transcription factors, is expressed at high levels in the developing eyes, ears, central nervous and urogenital systems, as well as in Wilms' tumor and renal cell carcinoma. Expression of PAX2 in the urogenital system is associated with proliferating cells of the ureteric bud and the differentiating nephrogenic mesenchyme. To date, little is known about the molecular mechanisms controlling the regulation of PAX2 expression. This report describes the cloning and characterization of the human PAX2 gene promoter and localization of the transcription start sites in fetal kidney and Wilms' tumor. We identified two transcription start sites in a Wilms' tumor sample, which were found to be different from that in fetal kidney. The activity of a deletion series of the PAX2 promoter was assessed in NIH-3T3, COS-7, 293, and Madin-Darby canine kidney cells. Although some differences were observed in the activity of each promoter construct, the profile of activity for the promoter fragment series was similar in each experiment, regardless of cell type. The WT1 tumor suppressor protein, which has previously been shown to repress murine Pax2 expression in vitro, was shown to also repress expression from the human PAX2 promoter. |
